BlackRock Fund Advisors’s Kyntra Bio KYNB Stock Holding History

BlackRock Fund Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$52.3M	Buy	97,742 +10,902	+13%	+$5.44M	0.01%	1654
2016 Q3	$44.9M	Buy	86,840 +4,715	+6%	+$2.22M	0.01%	1654
2016 Q2	$33.7M	Buy	82,125 +3,873	+5%	+$1.77M	0.01%	1738
2016 Q1	$41.6M	Buy	78,252 +2,079	+3%	+$1.04M	0.01%	1563
2015 Q4	$58M	Buy	76,173 +30,311	+66%	+$20.1M	0.01%	1378
2015 Q3	$25.1M	Buy	45,862 +262	+0.6%	+$159K	0.01%	1848
2015 Q2	$26.8M	Buy	45,600 +36,130	+382%	+$21M	0.01%	1932
2015 Q1	$7.43M	Buy	9,470 +196	+2%	+$152K	﹤0.01%	2612
2014 Q4	$6.34M	Buy	+9,274	New	+$5.97M	﹤0.01%	2727

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

BlackRock Fund Advisors's KYNB Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Kyntra Bio (KYNB) stake by 13% in Q4 2016, buying an estimated $5.44M and bringing the position to 97,742 shares worth $52.3M. The position accounts for 0.01% of the portfolio, ranked #1654.

BlackRock Fund Advisors first reported a position in KYNB in Q4 2014 and has held it in 9 quarters since. The position peaked at $58M in Q4 2015. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

BlackRock Fund Advisors held 97,742 shares of Kyntra Bio worth $52.3M as of Q4 2016.
BlackRock Fund Advisors bought 10,902 Kyntra Bio shares in Q4 2016, an estimated $5.44M.
Kyntra Bio made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1654 holding.
BlackRock Fund Advisors first reported a position in Kyntra Bio in Q4 2014 and has held it in 9 quarters since.
BlackRock Fund Advisors's Kyntra Bio position peaked at $58M in Q4 2015.
140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.